Skip to content

Mace Consult launched as a new and independent business on 5 March 2026, through a carve-out from Mace Group. Mace Consult and Mace Construct operate as two independent businesses. Information, references and materials on this website may represent operations prior to this separation. Go to Mace Construct here.

Roche South Africa

Advancing South Africa’s healthcare

Key takeaways

Delivered 13,500 sq m of high-spec office and laboratory space across Cape Town and Johannesburg

Aligned with Roche’s global standards through full lifecycle project and cost management

Enhances South Africa and the region’s diagnostics and biotech capabilities

Under Roche’s global framework, Mace was appointed to provide project management and quantity surveying services for the fitout of new offices in Johannesburg and Cape Town. These strategic developments support the company’s long-term growth and innovation goals in South Africa. 

In Cape Town, Mace oversaw Roche’s relocation to Brackenfell, delivering an 8,500 square metre fitout designed to accommodate 300 employees. The new facility includes laboratories, biotech production areas, and office space, significantly boosting Roche’s diagnostics capabilities in the region.  

In Johannesburg, Mace delivered a 5,000 square metre office consolidation at Hertford Office Park, Midrand, integrating Roche’s diagnostics and diabetes departments alongside a canteen and training centre.  

The location was selected for its proximity to Gautrain and airport links, ensuring accessibility and operational efficiency.  

Mace’s role on both projects spanned the full project lifecycle – from feasibility and cost planning to procurement, value engineering, and delivery – ensuring alignment with Roche’s global standards and sustainability goals.  

Delivered on time and within budget, both projects exemplify Mace’s ability to manage complex, high-value developments that support innovation and long-term business success. 

Mace Logo

Mace Consult and Mace Group are now two independent businesses.

In 2025, a majority investment in Mace Consult by Private Equity at Goldman Sachs Alternatives was announced through a demerger from Mace Group.

This completed on 5 March 2026, with Mace Consult and Mace Group (which includes Mace Construct) now independent businesses. To continue, please choose whether you want to explore Mace Consult or Mace Construct.